FR2988722B1 - Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques - Google Patents

Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques

Info

Publication number
FR2988722B1
FR2988722B1 FR1253044A FR1253044A FR2988722B1 FR 2988722 B1 FR2988722 B1 FR 2988722B1 FR 1253044 A FR1253044 A FR 1253044A FR 1253044 A FR1253044 A FR 1253044A FR 2988722 B1 FR2988722 B1 FR 2988722B1
Authority
FR
France
Prior art keywords
processes
preparation
therapeutic uses
thienopyrimidine derivatives
novel thienopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1253044A
Other languages
English (en)
Other versions
FR2988722A1 (fr
Inventor
Jean-Christophe Carry
Fabienne Chatreaux
Stephanie Deprets
Olivier Duclos
Vincent Leroy
Sergio Mallart
Dominique Melon-Manguer
Maria Mendez-Perez
Fabrice Vergne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48095815&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2988722(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR1253044A priority Critical patent/FR2988722B1/fr
Priority to UAA201411826A priority patent/UA112685C2/uk
Priority to DK13716241.8T priority patent/DK2834248T3/en
Priority to MA37384A priority patent/MA37384B1/fr
Priority to SI201330203A priority patent/SI2834248T1/sl
Priority to PE2014001523A priority patent/PE20150289A1/es
Priority to CA2868685A priority patent/CA2868685C/fr
Priority to US13/855,246 priority patent/US9115140B2/en
Priority to PCT/EP2013/056958 priority patent/WO2013150036A1/fr
Priority to AU2013244992A priority patent/AU2013244992B2/en
Priority to EP13716241.8A priority patent/EP2834248B1/fr
Priority to PL13716241.8T priority patent/PL2834248T3/pl
Priority to HUE13716241A priority patent/HUE027895T2/en
Priority to MX2014011921A priority patent/MX355104B/es
Priority to SG11201406091RA priority patent/SG11201406091RA/en
Priority to MYPI2014002724A priority patent/MY166151A/en
Priority to ES13716241.8T priority patent/ES2577382T3/es
Priority to RS20160436A priority patent/RS54850B1/sr
Priority to PT137162418T priority patent/PT2834248E/pt
Priority to KR1020147030322A priority patent/KR102039764B1/ko
Priority to EA201491820A priority patent/EA025558B1/ru
Priority to JP2015503860A priority patent/JP6096278B2/ja
Priority to CN201710950612.0A priority patent/CN107652303B/zh
Priority to CN201380029174.4A priority patent/CN104540834B/zh
Priority to BR112014024489-8A priority patent/BR112014024489B1/pt
Priority to ARP130101067A priority patent/AR090572A1/es
Priority to UY0001034725A priority patent/UY34725A/es
Priority to TW102112260A priority patent/TWI579288B/zh
Publication of FR2988722A1 publication Critical patent/FR2988722A1/fr
Application granted granted Critical
Publication of FR2988722B1 publication Critical patent/FR2988722B1/fr
Priority to CR20140435A priority patent/CR20140435A/es
Priority to DO2014000216A priority patent/DOP2014000216A/es
Priority to ZA2014/07021A priority patent/ZA201407021B/en
Priority to PH12014502180A priority patent/PH12014502180A1/en
Priority to TNP2014000415A priority patent/TN2014000415A1/fr
Priority to CL2014002661A priority patent/CL2014002661A1/es
Priority to IL234960A priority patent/IL234960A/en
Priority to CO14219119A priority patent/CO7091179A2/es
Priority to HK15101753.8A priority patent/HK1201263A1/zh
Priority to US14/794,574 priority patent/US9744176B2/en
Priority to HRP20160649TT priority patent/HRP20160649T1/hr
Priority to CY20161100522T priority patent/CY1117843T1/el
Priority to US15/660,694 priority patent/US10220044B2/en
Priority to HK18107478.6A priority patent/HK1248214A1/zh
Priority to US16/245,131 priority patent/US10500212B2/en
Priority to US16/668,555 priority patent/US10736904B2/en
Priority to US16/915,782 priority patent/US10980816B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
FR1253044A 2012-04-03 2012-04-03 Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques Active FR2988722B1 (fr)

Priority Applications (45)

Application Number Priority Date Filing Date Title
FR1253044A FR2988722B1 (fr) 2012-04-03 2012-04-03 Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
UAA201411826A UA112685C2 (uk) 2012-04-03 2013-02-04 Тієнопіримідинові похідні, способи їхнього одержання і їхні терапевтичні застосування
ES13716241.8T ES2577382T3 (es) 2012-04-03 2013-04-02 Nuevos derivados de tienopirimidina, procedimientos para su preparación, y sus usos terapéuticos
KR1020147030322A KR102039764B1 (ko) 2012-04-03 2013-04-02 신규 티에노피리미딘 유도체, 그의 제조 방법 및 그의 치료 용도
SI201330203A SI2834248T1 (sl) 2012-04-03 2013-04-02 Novi derivati tienopirimidina, postopki njihove priprave in njihove terapevtske uporabe
PE2014001523A PE20150289A1 (es) 2012-04-03 2013-04-02 Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CA2868685A CA2868685C (fr) 2012-04-03 2013-04-02 Derives de thienopyrimidine, ses procedes de preparation et ses usages therapeutiques
US13/855,246 US9115140B2 (en) 2012-04-03 2013-04-02 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
PCT/EP2013/056958 WO2013150036A1 (fr) 2012-04-03 2013-04-02 Nouveaux dérivés de thiénopyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques
AU2013244992A AU2013244992B2 (en) 2012-04-03 2013-04-02 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
EP13716241.8A EP2834248B1 (fr) 2012-04-03 2013-04-02 Nouveaux dérivés de thiénopyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques
PL13716241.8T PL2834248T3 (pl) 2012-04-03 2013-04-02 Nowe pochodne tienopirymidynowe, sposoby ich otrzymywania i ich zastosowania terapeutyczne
HUE13716241A HUE027895T2 (en) 2012-04-03 2013-04-02 New thienopyrimidine derivatives, a process for their preparation and their therapeutic use
MX2014011921A MX355104B (es) 2012-04-03 2013-04-02 Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos.
SG11201406091RA SG11201406091RA (en) 2012-04-03 2013-04-02 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
MYPI2014002724A MY166151A (en) 2012-04-03 2013-04-02 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
BR112014024489-8A BR112014024489B1 (pt) 2012-04-03 2013-04-02 derivados de tienopirimidina, processos para a preparação dos mesmos, medicamento e composição farmacêutica
RS20160436A RS54850B1 (sr) 2012-04-03 2013-04-02 Novi tienopirimidin derivati, procesi za pripremu istih i terapijska korišćenja toga
PT137162418T PT2834248E (pt) 2012-04-03 2013-04-02 Novos derivados da tienopirimidina, processos para a sua preparação e sua utilização terapêutica
MA37384A MA37384B1 (fr) 2012-04-03 2013-04-02 Nouveaux dérivés de thiénopyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques.
EA201491820A EA025558B1 (ru) 2012-04-03 2013-04-02 Тиенопиримидиновые производные, способы их получения и их терапевтические применения
JP2015503860A JP6096278B2 (ja) 2012-04-03 2013-04-02 新規なチエノピリミジン誘導体、その製造のための方法およびその治療的使用
CN201710950612.0A CN107652303B (zh) 2012-04-03 2013-04-02 新噻吩并嘧啶衍生物、其制备方法及其治疗用途
CN201380029174.4A CN104540834B (zh) 2012-04-03 2013-04-02 新噻吩并嘧啶衍生物、其制备方法及其治疗用途
DK13716241.8T DK2834248T3 (en) 2012-04-03 2013-04-02 UNKNOWN THIENOPYRIMIDINE DERIVATIVES, METHODS OF PRODUCING THEREOF, AND THERAPEUTIC APPLICATIONS THEREOF
ARP130101067A AR090572A1 (es) 2012-04-03 2013-04-03 Derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
TW102112260A TWI579288B (zh) 2012-04-03 2013-04-03 新穎噻吩并嘧啶衍生物及其製備方法與治療用途
UY0001034725A UY34725A (es) 2012-04-03 2013-04-03 Nuevos derivados de tienopirimidina, procesos para su preparación y sus usos terapéuticos.
CR20140435A CR20140435A (es) 2012-04-03 2014-09-22 Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
DO2014000216A DOP2014000216A (es) 2012-04-03 2014-09-25 Nuevos derivados de tienopirimidina en particular como agentes anticancerosos mediante la inhibición de la alk quinasa, procesos para su preparación y sus usos terapéuticos
ZA2014/07021A ZA201407021B (en) 2012-04-03 2014-09-26 Novel thienopyrimidine derivatives,processes for the preparation thereof and therapeutic uses thereof
PH12014502180A PH12014502180A1 (en) 2012-04-03 2014-09-29 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
TNP2014000415A TN2014000415A1 (en) 2012-04-03 2014-09-30 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
CL2014002661A CL2014002661A1 (es) 2012-04-03 2014-10-02 Compuestos derivados de tienopirimidina o sus sales, como inhibidores de la alk quinasa; su proceso de preparacion; composicion farmaceutica que los comprende, util para el tratamiento del cancer.
IL234960A IL234960A (en) 2012-04-03 2014-10-02 Theophenimidine derivatives, their preparation processes, and their medical uses
CO14219119A CO7091179A2 (es) 2012-04-03 2014-10-03 Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
HK15101753.8A HK1201263A1 (zh) 2012-04-03 2015-02-17 新噻吩並嘧啶衍生物、其製備方法及其治療用途
US14/794,574 US9744176B2 (en) 2012-04-03 2015-07-08 Therapeutic uses of novel thienopyrimidine derivatives
HRP20160649TT HRP20160649T1 (hr) 2012-04-03 2016-06-10 Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba
CY20161100522T CY1117843T1 (el) 2012-04-03 2016-06-15 Νεα παραγωγα θειενοπυριμιδινης, διεργασιες για την παρασκευη αυτων και θεραπευτικες χρησεις αυτων
US15/660,694 US10220044B2 (en) 2012-04-03 2017-07-26 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
HK18107478.6A HK1248214A1 (zh) 2012-04-03 2018-06-08 新噻吩並嘧啶衍生物、其製備方法及其治療用途
US16/245,131 US10500212B2 (en) 2012-04-03 2019-01-10 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
US16/668,555 US10736904B2 (en) 2012-04-03 2019-10-30 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
US16/915,782 US10980816B2 (en) 2012-04-03 2020-06-29 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1253044A FR2988722B1 (fr) 2012-04-03 2012-04-03 Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques

Publications (2)

Publication Number Publication Date
FR2988722A1 FR2988722A1 (fr) 2013-10-04
FR2988722B1 true FR2988722B1 (fr) 2014-05-09

Family

ID=48095815

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1253044A Active FR2988722B1 (fr) 2012-04-03 2012-04-03 Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques

Country Status (38)

Country Link
US (6) US9115140B2 (fr)
EP (1) EP2834248B1 (fr)
JP (1) JP6096278B2 (fr)
KR (1) KR102039764B1 (fr)
CN (2) CN104540834B (fr)
AR (1) AR090572A1 (fr)
AU (1) AU2013244992B2 (fr)
BR (1) BR112014024489B1 (fr)
CA (1) CA2868685C (fr)
CL (1) CL2014002661A1 (fr)
CO (1) CO7091179A2 (fr)
CR (1) CR20140435A (fr)
CY (1) CY1117843T1 (fr)
DK (1) DK2834248T3 (fr)
DO (1) DOP2014000216A (fr)
EA (1) EA025558B1 (fr)
ES (1) ES2577382T3 (fr)
FR (1) FR2988722B1 (fr)
HK (2) HK1201263A1 (fr)
HR (1) HRP20160649T1 (fr)
HU (1) HUE027895T2 (fr)
IL (1) IL234960A (fr)
MA (1) MA37384B1 (fr)
MX (1) MX355104B (fr)
MY (1) MY166151A (fr)
PE (1) PE20150289A1 (fr)
PH (1) PH12014502180A1 (fr)
PL (1) PL2834248T3 (fr)
PT (1) PT2834248E (fr)
RS (1) RS54850B1 (fr)
SG (1) SG11201406091RA (fr)
SI (1) SI2834248T1 (fr)
TN (1) TN2014000415A1 (fr)
TW (1) TWI579288B (fr)
UA (1) UA112685C2 (fr)
UY (1) UY34725A (fr)
WO (1) WO2013150036A1 (fr)
ZA (1) ZA201407021B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988722B1 (fr) 2012-04-03 2014-05-09 Sanofi Sa Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
JP2017516855A (ja) * 2014-05-28 2017-06-22 シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド 特定のタンパク質キナーゼ阻害剤
CN111440189B (zh) * 2015-04-24 2022-08-09 广州再极医药科技有限公司 稠环嘧啶氨基衍生物、其制备方法、中间体、药物组合物及应用
WO2017114351A1 (fr) * 2015-12-27 2017-07-06 Chongqing Fochon Pharmaceutical Co., Ltd. Inhibiteurs de certaines protéines kinases
WO2017193872A1 (fr) * 2016-05-07 2017-11-16 Shanghai Fochon Pharmaceutical Co., Ltd. Certains inhibiteurs de protéines kinases
CN111094255B (zh) 2017-09-14 2023-10-03 第一三共株式会社 具有环状结构的化合物
HRP20220331T1 (hr) 2018-03-08 2022-05-13 Incyte Corporation Spojevi aminopirazin diola kao inhibitori pi3k-y
CN110551142B (zh) * 2018-05-31 2023-05-12 上海再极医药科技有限公司 一种稠环嘧啶类化合物的盐、晶型及其制备方法和应用
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110922421B (zh) * 2019-12-17 2023-05-05 安徽英特美科技有限公司 一种n-甲基-1,2,5,6-四氢吡啶-4-硼酸频哪醇酯的合成方法
WO2021180032A1 (fr) * 2020-03-13 2021-09-16 Guangzhou Maxinovel Pharmaceuticals Co., Ltd. Nouveaux procédés thérapeutiques
CN116731035A (zh) * 2022-03-08 2023-09-12 广州再极医药科技有限公司 一种噻吩并嘧啶类化合物、中间体、其制备方法、组合物和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
SK6652000A3 (en) * 1997-11-11 2002-05-09 Pfizer Prod Inc Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
EP1181296A1 (fr) 1999-06-03 2002-02-27 Abbott Laboratories Composes anti-inflammatoires inhibant l'adhesion cellulaire
DE10042997A1 (de) 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
WO2007084815A2 (fr) 2006-01-19 2007-07-26 Janssen Pharmaceutica, N.V. Inhibiteurs de la thienopyrimidine kinase substituee
MX2008013583A (es) * 2006-04-26 2008-10-31 Genentech Inc Compuestos del inhibidor de fosfoinositido 3-cinasa y composiciones farmaceuticas que los contienen.
BRPI0720264B1 (pt) 2006-12-08 2022-03-03 Novartis Ag Compostos e composições como inibidores de proteína cinase
EP2215094B1 (fr) * 2007-11-15 2016-01-27 YM BioSciences Australia Pty Ltd Composés hétérocycliques à teneur en n
DE102008017853A1 (de) 2008-04-09 2009-10-15 Merck Patent Gmbh Thienopyrimidine
KR101147550B1 (ko) * 2009-10-22 2012-05-17 한국과학기술연구원 단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
KR101094446B1 (ko) * 2009-11-19 2011-12-15 한국과학기술연구원 단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
WO2012004900A1 (fr) 2010-07-09 2012-01-12 Aska Pharmaceutical Co., Ltd. Composés thiénopyrimidines
FR2988722B1 (fr) 2012-04-03 2014-05-09 Sanofi Sa Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques

Also Published As

Publication number Publication date
KR20150001781A (ko) 2015-01-06
AU2013244992B2 (en) 2017-04-20
ZA201407021B (en) 2015-11-25
CA2868685A1 (fr) 2013-10-10
US20200078370A1 (en) 2020-03-12
CA2868685C (fr) 2021-01-12
CN107652303A (zh) 2018-02-02
US10220044B2 (en) 2019-03-05
JP2015512434A (ja) 2015-04-27
AR090572A1 (es) 2014-11-19
PE20150289A1 (es) 2015-03-05
TN2014000415A1 (en) 2015-12-21
CN104540834B (zh) 2017-11-14
SI2834248T1 (sl) 2016-07-29
CR20140435A (es) 2015-03-13
US9115140B2 (en) 2015-08-25
WO2013150036A1 (fr) 2013-10-10
AU2013244992A1 (en) 2014-10-23
DOP2014000216A (es) 2017-09-15
MY166151A (en) 2018-06-06
US10736904B2 (en) 2020-08-11
US10500212B2 (en) 2019-12-10
MA37384B1 (fr) 2017-03-31
FR2988722A1 (fr) 2013-10-04
RS54850B1 (sr) 2016-10-31
ES2577382T3 (es) 2016-07-14
MX2014011921A (es) 2015-02-24
US20170319594A1 (en) 2017-11-09
CN104540834A (zh) 2015-04-22
US20190151330A1 (en) 2019-05-23
HK1201263A1 (zh) 2015-08-28
CO7091179A2 (es) 2014-10-21
US9744176B2 (en) 2017-08-29
US20150352124A1 (en) 2015-12-10
UA112685C2 (uk) 2016-10-10
PH12014502180B1 (en) 2014-12-10
MX355104B (es) 2018-04-05
KR102039764B1 (ko) 2019-11-01
JP6096278B2 (ja) 2017-03-15
MA37384A1 (fr) 2016-06-30
CY1117843T1 (el) 2017-05-17
CN107652303B (zh) 2020-08-04
HUE027895T2 (en) 2016-10-28
SG11201406091RA (en) 2014-10-30
PH12014502180A1 (en) 2014-12-10
EP2834248B1 (fr) 2016-03-16
HK1248214A1 (zh) 2018-10-12
IL234960A (en) 2017-06-29
CL2014002661A1 (es) 2014-12-26
DK2834248T3 (en) 2016-07-04
HRP20160649T1 (hr) 2016-07-15
UY34725A (es) 2013-09-30
TWI579288B (zh) 2017-04-21
PL2834248T3 (pl) 2016-09-30
BR112014024489B1 (pt) 2020-11-10
US20130261106A1 (en) 2013-10-03
EA025558B1 (ru) 2017-01-30
TW201345914A (zh) 2013-11-16
US10980816B2 (en) 2021-04-20
EP2834248A1 (fr) 2015-02-11
US20200323874A1 (en) 2020-10-15
PT2834248E (pt) 2016-06-24
EA201491820A1 (ru) 2015-02-27

Similar Documents

Publication Publication Date Title
FR2988722B1 (fr) Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
FR22C1047I2 (fr) Derives de benzimidazole-proline
HUE044048T2 (hu) Eljárás tienopirimidin származék elõállítására
CO7071126A2 (es) Derivados de piridona
PL2888269T3 (pl) Hapteny olanzapiny
SG11201605091RA (en) Processes to form ethylene-based polymers using asymmetrical polyenes
AR092198A1 (es) Derivados de pirazolopirimidinas
FR2959510B1 (fr) Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques
CO7020919A2 (es) Derivados de tetrahidro-quinazolinona
BR112015001100A2 (pt) método de detecção de câncer
EP2927254A4 (fr) Procédé de production de copolymère polyacétal
FR2995231B1 (fr) Procede de trefilage
FR2988101B1 (fr) Production de luteine en mode mixotrophe par scenedesmus
FI20125137A (fi) Prosessikalibraattori
FR2967672B1 (fr) Derives de nitrobenzothiazoles, leur preparation et leurs applications therapeutiques
BR112014027919A2 (pt) compostos complexos de germânio, métodos de produção dos mesmos e medicamentos.
FR2991986B1 (fr) Nouveaux derives de resorcinol et leurs applications cosmetiques
FR2988102B1 (fr) Production de polysaccharides en mode mixotrophe par nostoc
CO6930059A1 (es) Formulaciones farmacéuticas y proceso de producción de formulaciones farmacéuticas
FR3000104B1 (fr) Derives de triclosane et leurs utilisations
FR2991983B1 (fr) Nouveaux derives de resorcinol et leurs applications cosmetiques
EP2870133A4 (fr) Dérivés tétrahydro-isohumulone et procédés de fabrication et d'utilisation associés
FR2990635B1 (fr) Procede de brasage
TH1401005856A (th) สารอนุพันธ์ไธอีโนไพริมิดีนชนิดใหม่, กระบวนการสำหรับการเตรียมของสารนั้น และ การใช้ในเชิงบำบัดของสารนั้น
PL398891A1 (pl) Sposób wytwarzania 4',5,6,7-tetrahydroksyflawanonu oraz 4',5,7,8-tetrahydroksyflawanonu

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13